Beta-hemolysin production by group B streptococci (GBS) is speculated to be a major virulence factor of the organism. A virulent, beta-hemolytic group B streptococcus strain was mutagenized with the self-conjugative transposon Tn916 to derive isogenic strains with mutations only in the gene(s) responsible for beta-hemolysin biosynthesis. There was no significant difference between the virulence of the parent strain and that of the mutant strains in a neonatal rat sepsis model. Group B streptococci (GBS) are a leading cause of infant morbidity and mortality. The characteristics of the organisms that contribute to their virulence in neonates are not well understood, with the exception of the type-specific capsular polysaccharide (1; C. E. Rubens, M. R. Wessels, L. M. Heggen, and D. L. Kasper, Proc. Natl. Acad. Sci. USA, in press). Hemolysins have been shown to be major virulence factors in other gram-positive species (2, 5). Although beta-hemolysis is a property of all but 1 to 2% of GBS clinical isolates, its role as a virulence factor is not known. Marchlewicz and Duncan (7) have isolated a GBS betahemolysin with characteristics similar to those of streptolysin S produced by group A streptococci. This hemolysin cannot be detected in a soluble form and is cell bound or requires association with a carrier, making it difficult to characterize (7). The focus of this study was to derive isogenic strains of GBS differing only in their ability to produce beta-hemolysin and to determine the importance of beta-hemolysin as a virulence factor.
Group B streptococci (GBS) are a leading cause of infant morbidity and mortality. The characteristics of the organisms that contribute to their virulence in neonates are not well understood, with the exception of the type-specific capsular polysaccharide (1; C. E. Rubens, M. R. Wessels, L. M. Heggen, and D. L. Kasper, Proc. Natl. Acad. Sci. USA, in press). Hemolysins have been shown to be major virulence factors in other gram-positive species (2, 5). Although beta-hemolysis is a property of all but 1 to 2% of GBS clinical isolates, its role as a virulence factor is not known. Marchlewicz and Duncan (7) have isolated a GBS betahemolysin with characteristics similar to those of streptolysin S produced by group A streptococci. This hemolysin cannot be detected in a soluble form and is cell bound or requires association with a carrier, making it difficult to characterize (7) . The focus of this study was to derive isogenic strains of GBS differing only in their ability to produce beta-hemolysin and to determine the importance of beta-hemolysin as a virulence factor.
Mutants isogenic in beta-hemolysin production were derived by transposon mutagenesis with Tn916, a 16.4-kilobase (kb) transposon which carries a tetracycline resistance (Tetr) gene (3, 8) and is capable of self-conjugation with several gram-positive species. The recipient strain, COH31C, is a type III streptomycin-resistant mutant of a virulent GBS clinical isolate which exhibits a large zone of beta-hemolysis on 5% sheep blood agar. CG110 is a Streptococcus faecalis strain which transfers Tn916 at a high frequency (3, 8). COH31C and CG110 were grown in Todd-Hewitt broth to an optical density of 0.4 (600 nm), mixed in a ratio of 10 ml to 1 ml, respectively, on a nitrocellulose filter, and incubated on 5% sheep blood agar for 18 h at 37°C. Cells were removed from the filter with 2 ml of Todd-Hewitt broth and plated on 5% sheep blood agar containing 10 FLg of tetracycline and 750 ,ug of streptomycin per ml. Cells were grown anaerobically for 32 h at 24°C. The frequency of transfer of Tn9O6 from CG110 to COH31C was approximately 5 x 10-7 transconjugants per available recipient cell. Approximately 10-3 transconjugants were non-beta-hemolytic. Two non-beta-hemolytic (Hly-) transconjugants designated COH31C5 and COH31C12 were obtained and further analyzed. Both mutants were confirmed to be GBS by agglutination with anti-GBS type III capsular polysaccharide serum and anti-* Corresponding author.
GBS group polysaccharide serum and by the presence of the CAMP factor.
The presence of the Tn9O6 transposon insertion sequence in the genomes of COH31C5 and COH3C12 was demonstrated by Southern blot DNA-DNA hybridization. Total cellular DNA from the mutants was isolated by a modification of the procedure of Hull et al. (4) in which mutanolysin (50 p.g/ml) instead of lysozyme was used to lyse the GBS cells and the DNA was harvested from a cesium chloride gradient. Restriction enzyme digestion of DNA with EcoRI and HindlIl, agarose gel electrophoresis, Southern transfer of DNA fragments to nitrocellulose, and hybridization with a 32P-Tn916 DNA probe have been described previously (6) . The 32P-Tn9J6 probe was prepared from the 17-kb EcoRI fragment of plasmid pAM120, which contains the Tn9J6 sequence. This fragment was electroluted from low-meltingtemperature agarose (6) and labeled with 32P-deoxynucleotides in vitro by nick translation as described previously (9) . EcoRI does not cut within the Tn9O6 sequence (3); therefore, the number of DNA fragments which hybridize to the 32P-Tn916 probe represent the number of transposon sequences within the chromosome of the mutant. Figure 1A shows the presence of two Tn9O6 insertion sequences in EcoRI digests of total cellular DNA from both COH31C5 and COH31C12. The EcoRI fragments containing the Tn916 insertion sequences were 24.2 and 24.7 kb in COH31C5 and 24.7 and 25.2 kb in COH31C12. To determine whether the 24.7-kb EcoRI fragments from both Hly-mutants were identical, we digested total cellular DNA from COH31C5 and COH31C12 with EcoRI and HindIII and hybridized the DNA fragments to the 32P-Tn9J6 probe (Fig. 1B) . The Tn9O6 insertion sequence is known to contain a single HindlIl cleavage site (3). Digestion of the 24.7-kb EcoRI fragments with HindIll yielded identical fragments of 7.5 (Fig. 1B , open arrowheads) and 17.2 (Fig. 1B, closed Zelig et al. (11) . The bacteria were grown in 10 ml of Todd-Hewitt broth to an optical density of 0.4 (600 nm), harvested at 12,000 rpm and 4°C, washed twice with 10 ml of sterile phosphate-buffered saline, and resuspended in 1 ml of sterile phosphate-buffered saline. Tenfold serial dilutions were used for injection and cell counts. Three litters of 12 infant rats less than 24 h old from timed-pregnant SpragueDawley females were randomized, injected subcutaneously with the bacterial suspension at the tail base, and returned to their mothers. The 50% lethal dose (LD50) of COH31C (parent strain) was 106 CFU/g of body weight. There was no significant difference between the LD50s of the Hly-mutants and the LD50 of the parent strain (Table 1) . In contrast, a loss of virulence in the mutagenized GBS strain (COH31-15), which produces beta-hemolysin but not the type III capsule, was shown by a .100-fold difference in the LD50. Death from GBS sepsis was confirmed by culturing homogenates of spleens removed from dead animals. Revertant Hly+ colonies from the spleens of animals injected with COH31C5 or COH31C12 were not observed.
Despite numerous attempts in vitro, we were unable to isolate revertants to beta-hemolysin (Hly+) production from these two mutants. Reversion to tetracycline sensitivity was also not observed.
The technique of transposon mutagenesis has been shown to be a useful tool in the investigation of virulence factors. We recently found that the loss of the GBS capsular polysaccharide through transposon mutagenesis is associated with a loss of the virulence of the organism (Rubens et al., in press). The technique has been used to demonstrate that beta-hemolysin is a virulence factor on the chromosome of Listeria monocytogenes (2) and on a conjugative plasmid of S. faecalis (5) and to inactivate streptolysin S production in S. pyogenes (8) .
In our study, isogenic Hly-mutants of a virulent strain of GBS were obtained by the technique of transposon mutagenesis. This phenotypic change was shown to be caused by site-specific mutations in the GBS chromosome. We postulate that because one of these sites was common to two different Hly-mutants, this region of the GBS genome is responsible for beta-hemolysin expression. No measurable effect on virulence was observed when the isogenic Hlymutants were compared with the wild-type strain in a neonatal rat sepsis model.
The importance of beta-hemolysin in GBS infections has been in question because of the occasional finding of nonbeta-hemolytic clinical isolates. In contrast, all L. monocytogenes clinical isolates are beta-hemolytic (2). Roe et al. (10) reported that 4 of 11 GBS isolates from blood cultures of neonates were non-beta-hemolytic. The observation of virulent but non-beta-hemolytic clinical strains is consistent with our results, which suggest that beta-hemolysin is not required in the pathogenesis of systemic infections caused by GBS. The recommendation of Roe et 
